Align Technology, Inc. vs Merck & Company, Inc. — Stock Comparison
Align Technology, Inc. (ALGN) and Merck & Company, Inc. (MRK) are both listed on US exchanges. This page compares their Q·Score ratings, key fundamentals (P/E, margins, growth), and Wall Street analyst consensus side by side. Data sourced from Yahoo Finance and updated on each page load.
Align Technology, Inc. narrowly edges Merck & Company, Inc. on Q·Score (6.9 vs 6.3 out of 10), led by Valuation (8.7 vs 6.5) and Health (8.5 vs 7). Merck & Company, Inc. scores higher on Growth, reflecting stronger revenue and earnings momentum. Analyst consensus targets imply greater upside for ALGN (+41.6%) than for MRK (+4.7%).
Price Performance
Normalised to 100 at period start — shows relative performance.
Q·Score Breakdown
Consensus analyst target of $208.60 is 42% above current price.
⚠ earnings contracting 12% year-over-year.
71% of 28 covering analysts have a positive rating.
⚠ weak profitability metrics drag quality score.
Analyst Consensus
Fundamentals
Frequently Asked Questions
ALGN vs MRK: which stock scores better overall?
Based on Q·Score, Align Technology, Inc. (ALGN) scores 6.9/10 versus Merck & Company, Inc. (MRK) at 6.3/10. The Q·Score measures five dimensions: Quality, Health, Growth, Valuation, and Sentiment. For informational purposes only — not financial advice.
Which has better revenue growth: ALGN or MRK?
Merck & Company, Inc. (MRK) scores higher on Growth (6.4/10 vs 4.8/10). Align Technology, Inc. reports revenue growth (4.3% YoY) while Merck & Company, Inc. reports (5.1% YoY). Growth scores reflect revenue and earnings momentum relative to sector peers.
Is ALGN or MRK more attractively valued?
Align Technology, Inc. (ALGN) scores higher on Valuation (8.7/10 vs 6.5/10). ALGN trades at 11.7× P/E versus MRK at 15.3×. Valuation is assessed using P/E ratio, analyst price targets, and 52-week range positioning relative to sector peers.
What do analysts say about ALGN vs MRK?
There are 15 analysts covering ALGN with a consensus price target of $208.60, and 26 analysts covering MRK with a consensus target of $152.96. Analyst consensus ratings are aggregated from Wall Street research and do not constitute investment advice.
Which is more profitable: ALGN or MRK?
Align Technology, Inc. (ALGN) scores higher on Quality (6/10 vs 4.9/10). Net profit margin: ALGN at 10.0%, MRK at 4.8%. Quality scores reflect profit margins, return on equity, and free cash flow generation.
Which has stronger financial health: ALGN or MRK?
Align Technology, Inc. (ALGN) scores higher on Financial Health (8.5/10 vs 7/10). Market beta: ALGN at 1.64, MRK at 0.23. Health scores consider beta, debt-to-equity, and current ratio. All investments carry risk — this is not investment advice.
What are the market caps of ALGN and MRK?
Align Technology, Inc. (ALGN) has a market capitalisation of $10.5B, while Merck & Company, Inc. (MRK) has a market cap of $360.4B. Market cap data is sourced from Yahoo Finance and reflects the most recent available figures.
Do ALGN or MRK pay dividends?
ALGN does not currently pay a dividend, while MRK pays a dividend yield of 2.31%. Dividend yields fluctuate with share price and company payout decisions.
Related Comparisons
Q·Score is an educational tool and is not financial advice. Data provided by Yahoo Finance. Updated on each page load. How it's calculated →